CLINICAL_TRIALS trial_result · 2025-07-01

Clinical Trial Update: Reducing the Risk of Drug-Induced QT Interval Lengthening in Women [Phase 4]

This Phase 4 trial update reports results from a study aimed at reducing drug-induced QT interval prolongation in women.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Indiana University | Conditions: Long QT Syndrome, Abnormalities, Drug-Induced | Phase 4 | Status: COMPLETED | Results posted: 2025-07-01